Before a patient presenting with massive hepatosplenomegaly, B symptoms and cytopenias the diagnosis of lymphoproliferative disease was strongly considered namely aggressive B or T-cell/natural killer ...
non-Hodgkin lymphoma; HIV, human immunodeficiency virus; CCR4, CC chemokine receptor 4; CTLA-4, cytotoxic T-lymphocyte antigen 4; AECs, antibody-epitope conjugates; HLA, human leukocyte antigen; PTLD, ...
EBV latency has been classified into three types: type I (Burkitt's lymphoma), in which only ... and type III (lymphoproliferative diseases in immunosuppressed individuals), in which five EBNAs ...
Chronically immunocompromised patients have a markedly increased risk of developing lymphoproliferative ... Kaposi's sarcoma (KS), Hodgkin's disease (HD) and non-Hodgkin's lymphoma (NHL).
Conclusion Lymphomas complicating RA are mostly DLBCL. Risk of lymphoma in patients with RA was increased with markers of disease activity and severity, which supports the paradigm of a continuum ...
There are several subtypes of B-cell lymphoma, each with a distinct pathogenesis and disease course. 1 This article provides an overview of B-cell lymphoma so clinicians can pursue the correct ...
[45] Diffuse normolipemic plane xanthoma has been associated with monoclonal gammopathy, multiple myeloma, and lymphoproliferative and myeloproliferative disorders such as leukemia, lymphoma ...
CURE® spoke with an expert about follicular lymphoma, a disease that is still considered incurable. There have been a number of advancements in the treatment of follicular lymphoma in 2024.
17, 2024 — Axi-cel CAR T targets the CD19 molecule on large B-cell lymphoma cells. The ZUMA-7 trial demonstrated that axi-cel reduced the risk of disease progression, the need for new therapy ...
EBViously, a spin-off of Helmholtz Munich, officially started operations on 11 November 2024. The company is developing a ...
A systematic risk assessment of more prevalent lymphoma entities, such as B cell and non-intestinal lymphomas, in coeliac disease has not been performed. Aims: In light of the increasing number of ...